Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Acnamino MR 100mg capsules (Dexcel-Pharma)
0501030P0BHAAAC
|
Acnamino | Minocycline hydrochloride | Infections | 17 |
|
Canesten Thrush Oral 150mg capsules
0502010B0BDAAAB
|
Canesten (Fluconazole) | Fluconazole | Infections | 17 |
|
Doravirine 100mg tablets
0503010ATAAAAAA
|
Doravirine | Doravirine | Infections | 17 |
|
Erythroped PI SF 125mg/5ml oral suspension
0501050H0BDANAL
|
Erythroped | Erythromycin ethylsuccinate | Infections | 17 |
|
Rifadin 100mg/5ml syrup
0501090R0BBACAF
|
Rifadin | Rifampicin | Infections | 17 |
|
Clofazimine 100mg capsules
0501100C0AAAAAA
|
Clofazimine | Clofazimine | Infections | 16 |
|
Famvir 125mg tablets
0503021E0BBABAB
|
Famvir | Famciclovir | Infections | 16 |
|
Truvada 200mg/245mg tablets
0503010AABBAAAA
|
Truvada | Emtricitabine and tenofovir disoproxil | Infections | 16 |
|
Ceftazidime 1g powder for solution for injection vials
0501021H0AAABAB
|
Ceftazidime pentahydrate | Ceftazidime pentahydrate | Infections | 15 |
|
Co-amoxiclav 875mg/125mg tablets
0501013K0AAANAN
|
Co-amoxiclav | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | 15 |
|
Dolutegravir 50mg tablets
0503010AHAAAAAA
|
Dolutegravir | Dolutegravir | Infections | 15 |
|
Vancomycin 250mg/5ml oral liquid
0501070U0AAAKAK
|
Vancomycin hydrochloride (Systemic) | Vancomycin hydrochloride | Infections | 15 |
|
Xetinin XL 500mg tablets
0501050B0BHAAAE
|
Xetinin | Clarithromycin | Infections | 15 |
|
Cefuroxime 750mg powder for solution for injection vials
0501021J0AAABAB
|
Cefuroxime sod (Parent) | Cefuroxime sodium | Infections | 14 |
|
Fosfomycin 500mg capsules
0501130S0AAAAAA
|
Fosfomycin calcium | Fosfomycin calcium | Infections | 14 |
|
Vancomycin 500mg powder for solution for infusion vials
0501070U0AAACAC
|
Vancomycin hydrochloride (Systemic) | Vancomycin hydrochloride | Infections | 14 |
|
Distaclor 250mg/5ml oral suspension
0501021A0BBACAC
|
Distaclor | Cefaclor | Infections | 13 |
|
Praziquantel 600mg tablets
0505050P0AAAAAA
|
Praziquantel | Praziquantel | Infections | 13 |
|
Valtrex 250mg tablets
0503021A0BBABAC
|
Valtrex | Valaciclovir | Infections | 13 |
|
Voriconazole 50mg tablets
0502010D0AAABAB
|
Voriconazole | Voriconazole | Infections | 13 |
|
Xifaxanta 200mg tablets
0501070X0BCAAAA
|
Xifaxanta | Rifaximin | Infections | 13 |
|
Bramitob 300mg/4ml nebuliser solution 4ml ampoules
0501040U0BDAAAK
|
Bramitob | Tobramycin | Infections | 12 |
|
Distaclor 125mg/5ml oral suspension
0501021A0BBABAB
|
Distaclor | Cefaclor | Infections | 12 |
|
Piperacillin 4g / Tazobactam 500mg inf vials
0501014S0AAABAB
|
Piperacillin/tazobactam | Piperacillin sodium/tazobactam sodium | Infections | 12 |
|
Pyrazinamide 500mg tablets
0501090N0AACJCJ
|
Pyrazinamide | Pyrazinamide | Infections | 12 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.